In this webinar, Tom Major discusses the intricate landscape of cell and gene therapies, including the market trends, types, and compliance considerations. Throughout the session, he delves into the therapeutic potentials and regulatory challenges these advanced therapies face, especially in oncology and rare diseases. Attendees will gain insights into the complexities of safety data collection and the future of regenerative medicine, making it a must-watch for anyone interested in the evolving field of medicinal products.
- Cell and gene therapies have the potential to revolutionize the way we think about medicine, especially in treating rare and genetic diseases.
- The cell and gene therapy market is expected to grow at a CAGR of 52% over the next five years, with oncology commanding 44% of the market by 2029.
- Compliance and safety in cell and gene therapy require addressing challenges such as high regulatory scrutiny, long-term follow-up studies, and data management complexities.
